12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Rempex Pharmaceuticals preclinical data

In a mouse model of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumonia infection, Carbavance produced significantly lower bacterial counts in both lung and thigh infection models...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >